Symbols / BRKRP Stock $289.92 +0.00% Bruker Corporation

Healthcare • Medical Devices • United States • NMS
BRKRP (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Dr. Frank H. Laukien Ph.D.
Exch · Country NMS · United States
Market Cap —
Enterprise Value 45.57B
Income -22.50M
Sales 3.44B
FCF (ttm) 216.96M
Book/sh 16.15
Cash/sh 1.96
Employees 11,085
Insider 10d —
IPO Sep 04, 2025
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout —
P/E —
Forward P/E —
PEG —
P/S —
P/B 17.96
P/C —
EV/EBITDA 91.16
EV/Sales 13.26
Quick Ratio 0.81
Current Ratio 1.73
Debt/Eq 81.38
LT Debt/Eq —
EPS (ttm) —
EPS next Y —
EPS Growth 8.50%
Revenue Growth -0.20%
EPS Gr Q/Q 89.80%
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA 2.90%
ROE -0.38%
ROIC —
Gross Margin 47.95%
Oper. Margin 6.58%
Profit Margin -0.25%
Shs Outstand —
Shs Float 103.57M
Insider Own 0.00%
Instit Own 98.50%
Short Float —
Short Ratio 0.15
Short Interest 2.48K
52W High 419.83
vs 52W High -30.94%
52W Low 250.00
vs 52W Low 15.97%
Beta 1.20
Impl. Vol. —
Rel Volume 0.00
Avg Volume 12.53K
Volume 18.00
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $289.92
Price $289.92
Change 0.00%
About

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$289.92
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
$289.92
Low
—
High
—
Mean
—
News
RSS: Latest BRKRP news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
3,436.50
+2.08%
3,366.40
+13.56%
2,964.50
+17.14%
2,530.70
Operating Revenue
3,436.50
+2.08%
3,366.40
+13.56%
2,964.50
+17.14%
2,530.70
Cost Of Revenue
1,858.80
+8.26%
1,716.90
+18.31%
1,451.20
+18.47%
1,225.00
Reconciled Cost Of Revenue
1,858.80
+8.26%
1,716.90
+18.31%
1,451.20
+18.47%
1,225.00
Gross Profit
1,577.70
-4.35%
1,649.50
+9.00%
1,513.30
+15.90%
1,305.70
Operating Expense
1,341.70
+5.62%
1,270.30
+24.03%
1,024.20
+21.45%
843.30
Research And Development
395.20
+4.97%
376.50
+27.71%
294.80
+24.97%
235.90
Selling General And Administration
946.50
+5.90%
893.80
+22.54%
729.40
+20.09%
607.40
General And Administrative Expense
946.50
+5.90%
893.80
+22.54%
729.40
+20.09%
607.40
Salaries And Wages
—
—
0.10
-90.00%
1.00
Other Gand A
946.50
+5.90%
893.80
+22.54%
729.40
+20.09%
607.40
Other Operating Expenses
—
—
10.30
+171.05%
3.80
Total Expenses
3,200.50
+7.14%
2,987.20
+20.68%
2,475.40
+19.68%
2,068.30
Operating Income
236.00
-37.76%
379.20
-22.47%
489.10
+5.77%
462.40
Total Operating Income As Reported
68.20
-73.05%
253.10
-42.07%
436.90
+0.97%
432.70
EBITDA
302.60
-31.01%
438.60
-35.07%
675.50
+30.23%
518.70
Normalized EBITDA
456.80
-18.81%
562.60
-6.89%
604.20
+10.26%
548.00
Reconciled Depreciation
220.30
+19.86%
183.80
+59.97%
114.90
+29.54%
88.70
EBIT
82.30
-67.70%
254.80
-54.55%
560.60
+30.37%
430.00
Total Unusual Items
-154.20
-24.35%
-124.00
-273.91%
71.30
+343.34%
-29.30
Special Income Charges
-171.70
-16.25%
-147.70
-274.59%
84.60
+460.00%
-23.50
Other Special Charges
35.30
-21.38%
44.90
—
—
Impairment Of Capital Assets
111.30
+4959.09%
2.20
-61.40%
5.70
+1800.00%
0.30
Restructuring And Mergern Acquisition
5.10
-93.29%
76.00
+170.05%
-108.50
-567.67%
23.20
Write Off
20.00
-18.70%
24.60
+35.16%
18.20
0.00
Net Income
-8.60
-107.60%
113.10
-73.53%
427.20
+44.03%
296.60
Pretax Income
22.00
-89.37%
206.90
-61.98%
544.20
+31.48%
413.90
Net Non Operating Interest Income Expense
-46.70
-20.98%
-38.60
-642.31%
-5.20
+56.67%
-12.00
Interest Expense Non Operating
60.30
+25.89%
47.90
+192.07%
16.40
+1.86%
16.10
Net Interest Income
-46.70
-20.98%
-38.60
-642.31%
-5.20
+56.67%
-12.00
Interest Expense
60.30
+25.89%
47.90
+192.07%
16.40
+1.86%
16.10
Interest Income Non Operating
14.80
+59.14%
9.30
+24.00%
7.50
+167.86%
2.80
Interest Income
14.80
+59.14%
9.30
+24.00%
7.50
+167.86%
2.80
Other Income Expense
-167.30
-25.13%
-133.70
-321.72%
60.30
+265.21%
-36.50
Other Non Operating Income Expenses
-13.10
-35.05%
-9.70
+11.82%
-11.00
-52.78%
-7.20
Gain On Sale Of Security
17.50
-26.16%
23.70
+278.20%
-13.30
-129.31%
-5.80
Tax Provision
29.30
-67.94%
91.40
-22.34%
117.70
+1.12%
116.40
Tax Rate For Calcs
0.00
+0.00%
0.00
-2.78%
0.00
-23.13%
0.00
Tax Effect Of Unusual Items
-32.38
-24.35%
-26.04
-269.08%
15.40
+287.06%
-8.23
Net Income Including Noncontrolling Interests
-8.30
-107.29%
113.80
-73.44%
428.50
+43.55%
298.50
Net Income From Continuing Operation Net Minority Interest
-8.60
-107.60%
113.10
-73.53%
427.20
+44.03%
296.60
Net Income From Continuing And Discontinued Operation
-8.60
-107.60%
113.10
-73.53%
427.20
+44.03%
296.60
Net Income Continuous Operations
-8.30
-107.29%
113.80
-73.44%
428.50
+43.55%
298.50
Minority Interests
-0.30
+57.14%
-0.70
+46.15%
-1.30
+31.58%
-1.90
Normalized Income
113.22
-46.36%
211.06
-43.16%
371.30
+16.88%
317.67
Net Income Common Stockholders
-22.50
-119.89%
113.10
-73.53%
427.20
+44.03%
296.60
Diluted NI Availto Com Stockholders
-22.50
-119.89%
113.10
-73.53%
427.20
+44.03%
296.60
Earnings From Equity Interest Net Of Tax
-1.00
+41.18%
-1.70
-185.00%
2.00
+100.00%
1.00
Preferred Stock Dividends
13.90
—
—
—
Total Other Finance Cost
1.20
—
-3.70
-184.62%
-1.30
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
6,241.40
+7.49%
5,806.70
+36.63%
4,249.90
+17.67%
3,611.80
Current Assets
2,212.50
+7.76%
2,053.20
-5.13%
2,164.20
+2.41%
2,113.20
Cash Cash Equivalents And Short Term Investments
298.80
+62.92%
183.40
-62.44%
488.30
-24.35%
645.50
Cash And Cash Equivalents
298.80
+62.92%
183.40
-62.44%
488.30
-24.35%
645.50
Other Short Term Investments
—
—
—
0.00
Receivables
736.00
+4.96%
701.20
+12.77%
621.80
+4.45%
595.30
Accounts Receivable
544.90
-3.64%
565.50
+14.94%
492.00
+4.08%
472.70
Gross Accounts Receivable
—
572.00
+15.18%
496.60
+3.89%
478.00
Allowance For Doubtful Accounts Receivable
—
-6.50
-41.30%
-4.60
+13.21%
-5.30
Other Receivables
116.90
+15.51%
101.20
+20.62%
83.90
+37.99%
60.80
Taxes Receivable
74.20
+115.07%
34.50
-24.84%
45.90
-25.73%
61.80
Inventory
1,094.60
+2.51%
1,067.80
+10.28%
968.30
+21.02%
800.10
Raw Materials
392.00
+0.85%
388.70
+4.71%
371.20
+23.36%
300.90
Work In Process
343.60
-1.52%
348.90
+10.80%
314.90
+12.99%
278.70
Finished Goods
243.10
+6.39%
228.50
+24.25%
183.90
+43.45%
128.20
Prepaid Assets
59.00
-3.59%
61.20
+10.27%
55.50
+28.18%
43.30
Assets Held For Sale Current
—
—
0.00
-100.00%
1.40
Hedging Assets Current
0.00
-100.00%
10.70
-10.83%
12.00
-18.92%
14.80
Other Current Assets
24.10
-16.61%
28.90
+57.92%
18.30
+42.97%
12.80
Total Non Current Assets
4,028.90
+7.34%
3,753.50
+79.96%
2,085.70
+39.18%
1,498.60
Net PPE
910.60
+11.76%
814.80
+17.85%
691.40
+28.47%
538.20
Gross PPE
1,602.60
+16.65%
1,373.80
+13.01%
1,215.60
+23.42%
984.90
Accumulated Depreciation
-692.00
-23.79%
-559.00
-6.64%
-524.20
-17.35%
-446.70
Properties
0.00
0.00
0.00
0.00
Land And Improvements
75.60
+59.16%
47.50
+22.11%
38.90
+6.28%
36.60
Buildings And Improvements
612.00
+13.19%
540.70
+8.55%
498.10
+14.64%
434.50
Machinery Furniture Equipment
749.20
+17.04%
640.10
+9.06%
586.90
+26.87%
462.60
Other Properties
165.80
+13.95%
145.50
+58.67%
91.70
+79.10%
51.20
Goodwill And Other Intangible Assets
2,447.30
+1.14%
2,419.80
+165.01%
913.10
+25.34%
728.50
Goodwill
1,547.70
+2.68%
1,507.30
+158.72%
582.60
+27.32%
457.60
Other Intangible Assets
899.60
-1.41%
912.50
+176.10%
330.50
+22.00%
270.90
Non Current Deferred Assets
421.70
+47.34%
286.20
-3.70%
297.20
+286.98%
76.80
Non Current Deferred Taxes Assets
421.70
+47.34%
286.20
-3.70%
297.20
+286.98%
76.80
Other Non Current Assets
249.30
+7.13%
232.70
+26.47%
184.00
+18.63%
155.10
Total Liabilities Net Minority Interest
3,731.10
-6.52%
3,991.50
+40.71%
2,836.60
+14.38%
2,480.00
Current Liabilities
1,279.20
-0.16%
1,281.30
+6.59%
1,202.10
+31.48%
914.30
Payables And Accrued Expenses
441.30
-20.81%
557.30
+26.86%
439.30
+25.84%
349.10
Payables
324.90
-13.73%
376.60
+4.58%
360.10
+27.51%
282.40
Accounts Payable
215.90
-7.77%
234.10
+15.49%
202.70
+13.62%
178.40
Dividends Payable
11.50
0.00
—
—
Current Accrued Expenses
116.40
-35.58%
180.70
+128.16%
79.20
+18.74%
66.70
Employee Benefits
—
—
76.60
+67.61%
45.70
Pensionand Other Post Retirement Benefit Plans Current
179.70
-4.31%
187.80
+12.79%
166.50
+22.34%
136.10
Total Tax Payable
97.50
-31.58%
142.50
-9.47%
157.40
+51.35%
104.00
Income Tax Payable
76.20
-36.29%
119.60
-13.77%
138.70
+62.22%
85.50
Current Debt And Capital Lease Obligation
51.80
-19.81%
64.60
-55.29%
144.50
+311.68%
35.10
Current Debt
16.60
-48.92%
32.50
-73.18%
121.20
+548.13%
18.70
Other Current Borrowings
16.60
-48.92%
32.50
-73.18%
121.20
+548.13%
18.70
Current Capital Lease Obligation
35.20
+9.66%
32.10
+37.77%
23.30
+42.07%
16.40
Current Deferred Liabilities
441.30
+0.71%
438.20
+9.55%
400.00
+8.05%
370.20
Current Deferred Revenue
441.30
+0.71%
438.20
+9.55%
400.00
+8.05%
370.20
Other Current Liabilities
165.10
+394.31%
33.40
-35.52%
51.80
+117.65%
23.80
Total Non Current Liabilities Net Minority Interest
2,451.90
-9.53%
2,710.20
+65.81%
1,634.50
+4.39%
1,565.70
Long Term Debt And Capital Lease Obligation
1,991.10
-8.69%
2,180.70
+76.56%
1,235.10
-0.02%
1,235.30
Long Term Debt
1,852.50
-10.15%
2,061.80
+77.70%
1,160.30
-3.35%
1,200.50
Long Term Capital Lease Obligation
138.60
+16.57%
118.90
+58.96%
74.80
+114.94%
34.80
Non Current Pension And Other Postretirement Benefit Plans
—
—
76.60
+67.61%
45.70
Non Current Deferred Liabilities
221.60
+1.42%
218.50
+37.25%
159.20
-2.87%
163.90
Non Current Deferred Revenue
109.10
+9.10%
100.00
+9.29%
91.50
-9.94%
101.60
Non Current Deferred Taxes Liabilities
112.50
-5.06%
118.50
+75.04%
67.70
+8.67%
62.30
Other Non Current Liabilities
239.20
-23.09%
311.00
+29.48%
240.20
+98.84%
120.80
Preferred Securities Outside Stock Equity
—
—
—
6.10
Common Stock Equity
2,456.50
+37.91%
1,781.20
+29.33%
1,377.20
+23.65%
1,113.80
Capital Stock
1.80
+0.00%
1.80
+5.88%
1.70
+0.00%
1.70
Common Stock
1.80
+0.00%
1.80
+5.88%
1.70
+0.00%
1.70
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
183.05
+0.32%
182.46
+3.70%
175.94
+0.32%
175.39
Ordinary Shares Number
152.14
+0.31%
151.68
+4.49%
145.16
-1.26%
147.02
Treasury Shares Number
30.90
+0.41%
30.78
+0.00%
30.78
+8.50%
28.37
Additional Paid In Capital
1,414.60
+98.29%
713.40
+152.17%
282.90
+10.38%
256.30
Retained Earnings
2,361.80
-1.87%
2,406.70
+3.57%
2,323.80
+20.65%
1,926.00
Gains Losses Not Affecting Retained Earnings
-79.50
+23.19%
-103.50
-1825.00%
6.00
-59.46%
14.80
Treasury Stock
1,242.20
+0.40%
1,237.20
+0.00%
1,237.20
+14.03%
1,085.00
Minority Interest
53.80
+58.24%
34.00
-5.82%
36.10
+100.56%
18.00
Other Equity Adjustments
-79.50
+23.19%
-103.50
-1825.00%
6.00
-59.46%
14.80
Total Equity Gross Minority Interest
2,510.30
+38.29%
1,815.20
+28.44%
1,413.30
+24.87%
1,131.80
Total Capitalization
4,309.00
+12.13%
3,843.00
+51.45%
2,537.50
+9.64%
2,314.30
Working Capital
933.30
+20.91%
771.90
-19.77%
962.10
-19.75%
1,198.90
Invested Capital
4,325.60
+11.61%
3,875.50
+45.77%
2,658.70
+13.96%
2,333.00
Total Debt
2,042.90
-9.01%
2,245.30
+62.75%
1,379.60
+8.60%
1,270.40
Net Debt
1,570.30
-17.82%
1,910.90
+140.91%
793.20
+38.26%
573.70
Capital Lease Obligations
173.80
+15.10%
151.00
+53.92%
98.10
+91.60%
51.20
Net Tangible Assets
9.20
+101.44%
-638.60
-237.60%
464.10
+20.45%
385.30
Tangible Book Value
9.20
+101.44%
-638.60
-237.60%
464.10
+20.45%
385.30
Interest Payable
7.10
-29.00%
10.00
—
—
Other Inventories
115.90
+13.96%
101.70
+3.46%
98.30
+6.50%
92.30
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
134.10
-46.64%
251.30
-28.22%
350.10
+27.59%
274.40
Cash Flow From Continuing Operating Activities
134.10
-46.64%
251.30
-28.22%
350.10
+27.63%
274.30
Net Income From Continuing Operations
-8.30
-107.29%
113.80
-73.44%
428.50
+43.55%
298.50
Depreciation Amortization Depletion
220.30
+19.86%
183.80
+59.97%
114.90
+29.54%
88.70
Depreciation
99.10
+17.00%
84.70
+24.93%
67.80
+31.40%
51.60
Amortization Cash Flow
121.20
+22.30%
99.10
+110.40%
47.10
+26.95%
37.10
Depreciation And Amortization
220.30
+19.86%
183.80
+59.97%
114.90
+29.54%
88.70
Amortization Of Intangibles
121.20
+22.30%
99.10
+110.40%
47.10
+26.95%
37.10
Other Non Cash Items
-21.10
-141.87%
50.40
+129.29%
-172.10
-739.78%
26.90
Stock Based Compensation
20.20
-20.16%
25.30
-18.12%
30.90
+11.55%
27.70
Asset Impairment Charge
228.30
+157.38%
88.70
+113.22%
41.60
+2500.00%
1.60
Deferred Tax
-104.50
-63.79%
-63.80
-161.48%
-24.40
-64.86%
-14.80
Deferred Income Tax
-104.50
-63.79%
-63.80
-161.48%
-24.40
-64.86%
-14.80
Operating Gains Losses
-56.00
-99.29%
-28.10
-251.89%
18.50
+283.17%
-10.10
Gain Loss On Investment Securities
—
—
-6.80
—
Net Foreign Currency Exchange Gain Loss
-56.00
-99.29%
-28.10
-251.89%
18.50
—
Gain Loss On Sale Of PPE
—
4.60
+154.12%
-8.50
+15.84%
-10.10
Change In Working Capital
-144.80
-21.89%
-118.80
-35.31%
-87.80
+39.07%
-144.10
Change In Receivables
54.20
+233.50%
-40.60
-4411.11%
-0.90
+98.67%
-67.90
Changes In Account Receivables
54.20
+233.50%
-40.60
-4411.11%
-0.90
+98.67%
-67.90
Change In Inventory
12.10
+117.34%
-69.80
+44.16%
-125.00
+9.35%
-137.90
Change In Payables And Accrued Expense
-158.20
-856.94%
20.90
-68.71%
66.80
+152.08%
26.50
Change In Accrued Expense
-26.70
-273.38%
15.40
-29.68%
21.90
—
Change In Payable
-131.50
-2490.91%
5.50
-87.75%
44.90
+69.43%
26.50
Change In Account Payable
-37.50
-280.29%
20.80
+1633.33%
1.20
-96.40%
33.30
Change In Other Working Capital
-52.90
-80.55%
-29.30
-2.09%
-28.70
-181.53%
35.20
Investing Cash Flow
-196.50
+88.82%
-1,757.30
-439.05%
-326.00
-29.57%
-251.60
Cash Flow From Continuing Investing Activities
-196.50
+88.82%
-1,757.30
-439.05%
-326.00
-29.57%
-251.60
Net PPE Purchase And Sale
-90.80
+21.25%
-115.30
-7.86%
-106.90
+7.29%
-115.30
Purchase Of PPE
-90.80
+21.25%
-115.30
-7.86%
-106.90
+17.26%
-129.20
Sale Of PPE
—
1.10
-90.09%
11.10
-20.14%
13.90
Capital Expenditure
-120.20
-4.25%
-115.30
-7.86%
-106.90
+17.26%
-129.20
Net Investment Purchase And Sale
-7.20
+85.09%
-48.30
-94.76%
-24.80
-153.91%
46.00
Purchase Of Investment
-7.20
+85.09%
-48.30
-94.76%
-24.80
+58.80%
-60.20
Sale Of Investment
—
4.80
-77.36%
21.20
-80.04%
106.20
Net Business Purchase And Sale
-73.90
+95.38%
-1,599.60
-605.91%
-226.60
-24.30%
-182.30
Purchase Of Business
-73.90
+95.38%
-1,599.60
-605.91%
-226.60
-24.30%
-182.30
Net Intangibles Purchase And Sale
-29.40
0.00
0.00
—
Purchase Of Intangibles
-29.40
0.00
0.00
—
Net Other Investing Changes
4.80
-18.64%
5.90
-81.73%
32.30
—
Financing Cash Flow
135.10
-89.01%
1,229.80
+735.88%
-193.40
+53.43%
-415.30
Cash Flow From Continuing Financing Activities
135.10
-89.01%
1,229.80
+735.88%
-193.40
+53.43%
-415.30
Net Issuance Payments Of Debt
-491.30
-156.09%
875.90
+4173.95%
-21.50
+80.58%
-110.70
Issuance Of Debt
754.00
-66.10%
2,224.00
+111100.00%
2.00
+566.67%
0.30
Repayment Of Debt
-1,245.30
+7.63%
-1,348.10
-5636.60%
-23.50
+78.83%
-111.00
Long Term Debt Issuance
754.00
-66.10%
2,224.00
+111100.00%
2.00
+566.67%
0.30
Long Term Debt Payments
-1,245.30
+7.63%
-1,348.10
-5636.60%
-23.50
+78.83%
-111.00
Net Long Term Debt Issuance
-491.30
-156.09%
875.90
+4173.95%
-21.50
+80.58%
-110.70
Short Term Debt Issuance
—
—
—
0.00
Short Term Debt Payments
—
—
—
0.00
Net Short Term Debt Issuance
—
—
—
0.00
Net Common Stock Issuance
-2.10
-100.51%
409.00
+386.41%
-142.80
+45.72%
-263.10
Common Stock Payments
-10.00
0.00
+100.00%
-152.30
+42.11%
-263.10
Common Stock Dividend Paid
-22.80
+24.50%
-30.20
-2.72%
-29.40
+1.34%
-29.80
Cash Dividends Paid
-32.90
-8.94%
-30.20
-2.72%
-29.40
+1.34%
-29.80
Repurchase Of Capital Stock
-10.00
0.00
+100.00%
-152.30
+42.11%
-263.10
Proceeds From Stock Option Exercised
—
6.00
-36.84%
9.50
+239.29%
2.80
Net Other Financing Charges
-8.30
+66.67%
-24.90
-8400.00%
0.30
+102.07%
-14.50
Changes In Cash
72.70
+126.32%
-276.20
-63.14%
-169.30
+56.87%
-392.50
Effect Of Exchange Rate Changes
43.70
+252.26%
-28.70
-335.25%
12.20
+140.00%
-30.50
Beginning Cash Position
186.70
-62.02%
491.60
-24.22%
648.70
-39.47%
1,071.70
End Cash Position
303.10
+62.35%
186.70
-62.02%
491.60
-24.22%
648.70
Free Cash Flow
13.90
-89.78%
136.00
-44.08%
243.20
+67.49%
145.20
Interest Paid Supplemental Data
71.00
+30.04%
54.60
+62.02%
33.70
+38.68%
24.30
Income Tax Paid Supplemental Data
222.50
+44.57%
153.90
+59.32%
96.60
-34.46%
147.40
Change In Income Tax Payable
-94.00
-514.38%
-15.30
-135.01%
43.70
+742.65%
-6.80
Change In Tax Payable
-94.00
-514.38%
-15.30
-135.01%
43.70
+742.65%
-6.80
Common Stock Issuance
7.90
-98.07%
409.00
+4205.26%
9.50
0.00
Issuance Of Capital Stock
677.60
+65.67%
409.00
+4205.26%
9.50
0.00
Net Preferred Stock Issuance
669.70
0.00
0.00
—
Preferred Stock Dividend Paid
-10.10
0.00
0.00
—
Preferred Stock Issuance
669.70
0.00
0.00
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category